{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:35:04Z","timestamp":1794897304998,"version":"4.9.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.carbpol.2026.125159","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:40:36Z","timestamp":1772264436000},"page":"125159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hyaluronic acid-based supramolecular peptide-drug conjugate prodrug nanosystems for precise multiple myeloma therapy"],"prefix":"10.1016","volume":"381","author":[{"given":"Xiangyu","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chendi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carbpol.2026.125159_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-019-0205-9","article-title":"Current status of autologous stem cell transplantation for multiple myeloma","volume":"9","author":"Al Hamed","year":"2019","journal-title":"Blood Cancer Journal"},{"key":"10.1016\/j.carbpol.2026.125159_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/leu.2013.174","article-title":"Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications","volume":"28","author":"Bjorklund","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.carbpol.2026.125159_bb0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/j.carbpol.2026.125159_bb0020","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1002\/anie.201900886","article-title":"NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy","volume":"58","author":"Chen","year":"2019","journal-title":"Angewandte Chemie, International Edition"},{"key":"10.1016\/j.carbpol.2026.125159_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108133","article-title":"Melphalan-loaded methoxy poly(ethylene glycol)-poly(d,l-lactide) copolymer nanomicelles in the treatment of multiple myeloma","volume":"34","author":"Chen","year":"2023","journal-title":"Chinese Chemical Letters"},{"key":"10.1016\/j.carbpol.2026.125159_bb0030","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and Management of Multiple Myeloma: A Review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.carbpol.2026.125159_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.addr.2019.01.010","article-title":"Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases","volume":"151-152","author":"Dheer","year":"2019","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.carbpol.2026.125159_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122019","article-title":"Radiolabeling and cytotoxicity of monoclonal antibody Isatuximab functionalized silver nanoparticles on the growth of multiple myeloma","volume":"624","author":"El-Shershaby","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.carbpol.2026.125159_bb0045","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1038\/s41467-020-19932-1","article-title":"Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma","volume":"11","author":"Federico","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.carbpol.2026.125159_bb0050","doi-asserted-by":"crossref","first-page":"18789","DOI":"10.1021\/jacs.3c03031","article-title":"Supramolecular Modulation of Tumor Microenvironment through Pillar[5]arene-Based Host-Guest Recognition to Synergize Cancer Immunotherapy","volume":"145","author":"Feng","year":"2023","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.carbpol.2026.125159_bb0055","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1021\/jm010926x","article-title":"Synthesis and in vitro evaluation of quaternary ammonium derivatives of chlorambucil and melphalan, anticancer drugs designed for the chemotherapy of chondrosarcoma","volume":"45","author":"Giraud","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.carbpol.2026.125159_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904742","article-title":"CD44-Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma","volume":"31","author":"Gu","year":"2019","journal-title":"Advanced Materials"},{"key":"10.1016\/j.carbpol.2026.125159_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122521","article-title":"Harnessing the CD44-targeted delivery of self-assembled hyaluronan nanogel to reverse the antagonism between Cisplatin and Gefitinib in NSCLC cancer therapy","volume":"344","author":"Guo","year":"2024","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2026.125159_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115787","article-title":"Novel dual ROS-sensitive and CD44 receptor targeting nanomicelles based on oligomeric hyaluronic acid for the efficient therapy of atherosclerosis","volume":"232","author":"Hou","year":"2020","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2026.125159_bb0075","doi-asserted-by":"crossref","first-page":"9573","DOI":"10.1002\/adma.201603463","article-title":"Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus","volume":"28","author":"Hu","year":"2016","journal-title":"Advanced Materials"},{"key":"10.1016\/j.carbpol.2026.125159_bb0080","doi-asserted-by":"crossref","first-page":"eadp9071","DOI":"10.1126\/sciadv.adp9071","article-title":"An \u201cAND\u201d logic gate-based supramolecular therapeutic nanoplatform for combatting drug-resistant non-small cell lung cancer","volume":"10","author":"Huang","year":"2024","journal-title":"Science Advances"},{"key":"10.1016\/j.carbpol.2026.125159_bb0085","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1016\/j.bmc.2005.04.084","article-title":"Recent advances in tumor-targeting anticancer drug conjugates","volume":"13","author":"Jaracz","year":"2005","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.carbpol.2026.125159_bb0090","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S2352-3026(22)00002-3","article-title":"Melflufen for multiple myeloma: a promise unfulfilled?","volume":"9","author":"Kapoor","year":"2022","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.carbpol.2026.125159_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121913","article-title":"Disease-driven engineering of peptide-targeted DM1 loaded liposomal nanoparticles for enhanced efficacy in treating multiple myeloma by exploring DM1 prodrug chemistry","volume":"292","author":"Khan","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.carbpol.2026.125159_bb0100","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/bc8001503","article-title":"Aqueous Solubilization of Fullerenes Using Poly(amidoamine) Dendrimers Bearing Cyclodextrin and Poly(ethylene Glycol)","volume":"19","author":"Kojima","year":"2008","journal-title":"Bioconjate Chem."},{"key":"10.1016\/j.carbpol.2026.125159_bb0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2643-3230.BCD-21-0028","article-title":"Bispecific Antibodies in Multiple Myeloma: Present and Future","volume":"2","author":"Lancman","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.carbpol.2026.125159_bb0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-med-070209-175325","article-title":"Multiple Myeloma","volume":"62","author":"Laubach","year":"2011","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.carbpol.2026.125159_bb0115","article-title":"Pillararene-Based Stimuli-Responsive Supramolecular Delivery Systems for Cancer Therapy","volume":"36","author":"Li","year":"2024","journal-title":"Advanced Materials"},{"key":"10.1016\/j.carbpol.2026.125159_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113921","article-title":"Hypoxia-sensitive macrocycle inclusion complexes for targeted protein degradation","volume":"384","author":"Lin","year":"2025","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.carbpol.2026.125159_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120255","article-title":"Combinatorial synthesis of a hyaluronan based polysaccharide library for enhanced CD44 binding","volume":"300","author":"Liu","year":"2023","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2026.125159_bb0130","article-title":"Cyclodextrins as versatile supramolecular building block in nanoscale drug delivery systems for precise tumor chemotherapy","author":"Liu","year":"2025","journal-title":"Chinese Chemical Letters"},{"key":"10.1016\/j.carbpol.2026.125159_bb0135","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","article-title":"Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma","volume":"373","author":"Lokhorst","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.carbpol.2026.125159_bb0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/leu.2015.223","article-title":"Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives","volume":"30","author":"Lonial","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.carbpol.2026.125159_bb0145","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1200\/JCO.19.01740","article-title":"Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma","volume":"38","author":"Lonial","year":"2020","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.carbpol.2026.125159_bb0150","doi-asserted-by":"crossref","first-page":"e822","DOI":"10.1016\/S2352-3026(22)00290-3","article-title":"Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1\/2 trial","volume":"9","author":"Lonial","year":"2022","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.carbpol.2026.125159_bb0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.carbpol.2026.125159_bb0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/bloodadvances.2019000524","article-title":"Long-term outcomes after autologous stem cell transplantation for multiple myeloma","volume":"4","author":"Nishimura","year":"2020","journal-title":"Blood Advances"},{"key":"10.1016\/j.carbpol.2026.125159_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114494","article-title":"Melphalan: Recent insights on synthetic, analytical and medicinal aspects","volume":"238","author":"Pahwa","year":"2022","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.carbpol.2026.125159_bb0170","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/acs.accounts.3c00585","article-title":"Molecular Recognition with Macrocyclic Receptors for Application in Precision Medicine","volume":"56","author":"Pan","year":"2023","journal-title":"Accounts of Chemical Research"},{"key":"10.1016\/j.carbpol.2026.125159_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2024.10.003","article-title":"Recent advances in targeted drug delivery systems for multiple myeloma","volume":"376","author":"Pant","year":"2024","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.carbpol.2026.125159_bb0180","doi-asserted-by":"crossref","first-page":"eabf7820","DOI":"10.1126\/sciadv.abf7820","article-title":"Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs","volume":"7","author":"Park","year":"2021","journal-title":"Science Advances"},{"key":"10.1016\/j.carbpol.2026.125159_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood-2020-134538","article-title":"Early versus late autologous stem cell transplant in newly diagnosed multiple myeloma: Long-term follow-up analysis of the IFM 2009 trial","volume":"136","author":"Perrot","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.carbpol.2026.125159_bb0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.eng.2024.01.001","article-title":"Enhanced Precision Therapy of Multiple Myeloma Through Engineered Biomimetic Nanoparticles with Dual Targeting","volume":"36","author":"Qi","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.carbpol.2026.125159_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107883","article-title":"Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow Homing","volume":"34","author":"Qu","year":"2022","journal-title":"Advanced Materials"},{"key":"10.1016\/j.carbpol.2026.125159_bb0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/bjh.14065","article-title":"A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells","volume":"174","author":"Ray","year":"2016","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.carbpol.2026.125159_bb0205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1200\/JCO.20.02259","article-title":"on behalf of the HORIZON (OP-106) Investigators, Melflufen and dexamethasone in heavily pretreated relapsed and refractory multiple myeloma","volume":"39","author":"Richardson","year":"2021","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.carbpol.2026.125159_bb0210","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/ejoc.201800447","article-title":"Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and \u03b1V\u03b23-Integrin Ligands for Tumor Targeting","volume":"23","author":"Rivas","year":"2018","journal-title":"European Journal of Organic Chemistry"},{"key":"10.1016\/j.carbpol.2026.125159_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13045-016-0283-0","article-title":"Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma, J. Hematol. Oncol","volume":"9","author":"Sanchez","year":"2016","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/j.carbpol.2026.125159_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102677","article-title":"Lenalidomide-utilizing self-assembled immunogenic cell death-inducing heparin\/doxorubicin nanocomplex for anticancer immunotherapy","volume":"62","author":"Seo","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.carbpol.2026.125159_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122989","article-title":"Recent advancements in nanomedicine as a revolutionary approach to treating multiple myeloma","volume":"356","author":"Shafiei","year":"2024","journal-title":"Life Sciences"},{"key":"10.1016\/j.carbpol.2026.125159_bb0230","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biomaterials.2017.02.016","article-title":"Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation","volume":"125","author":"Soiberman","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.carbpol.2026.125159_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116512","article-title":"Carbodiimide coupling versus click chemistry for nanoparticle surface functionalization: A comparative study for the encapsulation of sodium cholate by cellulose nanocrystals modified with \u03b2-cyclodextrin","volume":"244","author":"Tang","year":"2020","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2026.125159_bb0240","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1021\/acsnano.9b09618","article-title":"Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma","volume":"14","author":"Tang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.carbpol.2026.125159_bb0245","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1016\/S2352-3026(21)00057-0","article-title":"CAR T-cell therapy for multiple myeloma: state of the art and prospects","volume":"8","author":"Van De Donk","year":"2021","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.carbpol.2026.125159_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122096","article-title":"Anti-BCMA surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-\u03baB signaling in vivo","volume":"297","author":"Xiao","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.carbpol.2026.125159_bb0255","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1021\/jm4014168","article-title":"Targeted Polysaccharide Nanoparticle for Adamplatin Prodrug Delivery","volume":"56","author":"Yang","year":"2013","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.carbpol.2026.125159_bb0260","doi-asserted-by":"crossref","first-page":"14203","DOI":"10.1021\/jacs.4c03238","article-title":"Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs","volume":"146","author":"Yao","year":"2024","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.carbpol.2026.125159_bb0265","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11899-017-0382-1","article-title":"A Review of Autologous Stem Cell Transplantation in Lymphoma","volume":"12","author":"Zahid","year":"2017","journal-title":"Current Hematologic Malignancy Reports"},{"key":"10.1016\/j.carbpol.2026.125159_bb0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.carbpol.2026.125159_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.actbio.2022.03.035","article-title":"Redox-responsive self-assembled polymeric nanoprodrug for delivery of gemcitabine in B-cell lymphoma therapy","volume":"144","author":"Zhong","year":"2022","journal-title":"Acta Biomaterialia"},{"key":"10.1016\/j.carbpol.2026.125159_bb0280","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1039\/D0BM00772B","article-title":"Advancements in nanotechnology for the diagnosis and treatment of multiple myeloma","volume":"8","author":"Zhong","year":"2020","journal-title":"Biomaterials Science"},{"key":"10.1016\/j.carbpol.2026.125159_bb0285","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2020.02.004","article-title":"CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice","volume":"320","author":"Zhong","year":"2020","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.carbpol.2026.125159_bb0290","first-page":"1","article-title":"Engineering a macromolecular JAK inhibitor for treating acute inflammation and endotoxaemia","author":"Zhou","year":"2025","journal-title":"Nature Biomedical Engineering"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861726002754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861726002754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:45:44Z","timestamp":1777488344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861726002754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"alternative-id":["S0144861726002754"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2026.125159","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid-based supramolecular peptide-drug conjugate prodrug nanosystems for precise multiple myeloma therapy","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2026.125159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125159"}}